New MRI Biomarkers in Head and Neck Cancers



Status:Recruiting
Conditions:Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:3/8/2019
Start Date:March 16, 2018
End Date:March 2023
Contact:Amita Dave, PhD
Email:davea@mskcc.org
Phone:212-639-3184

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Quantitative Imaging Tools to Derive DW-MRI Oncological Biomarkers

Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of
the body. It uses magnetic fields and radio waves that cannot be felt. This makes specific
organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of
water in the tumor.

The purpose of this study is to see if new MRI methods can give us more information about the
tumor.


Inclusion Criteria:

- Age ≥ 18 years

- Group 1 patients: Presence of a suspicious metastatic lesion or suspicious for
recurrent disease in the head and neck region.

- Group 2 patients:

- Biopsy proven recurrent or metastatic or definitive squamous cell carcinoma of
the head and neck (HNSCC) or thyroid cancer

- Patients planning to undergo reatment at MSK

Exclusion Criteria:

- Patient would require anesthesia for the study

- Patients who are claustrophobic

- Patients selecting treatment outside of MSK

- Patients who have presence of a known contradiction to MRI

- Pacemaker

- Aneurysm clips

- Patients with implants that are contradicted for MR imaging will be excluded

- Pregnant

- Age and mental status wherein he /she is unable to cooperate for MRI study
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Amita Dave, PhD
Phone: 212-639-3184
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials